285 related articles for article (PubMed ID: 1327593)
1. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
[TBL] [Abstract][Full Text] [Related]
2. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies antigen specificity.
Lesavre P
Am J Kidney Dis; 1991 Aug; 18(2):159-63. PubMed ID: 1714231
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
8. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
9. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type.
Sobajima J; Ozaki S; Okazaki T; Osakada F; Sumita S; Mori K; Nakao K
Clin Exp Immunol; 1996 Jul; 105(1):120-4. PubMed ID: 8697619
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.
Ellerbroek PM; Oudkerk Pool M; Ridwan BU; Dolman KM; von Blomberg BM; von dem Borne AE; Meuwissen SG; Goldschmeding R
J Clin Pathol; 1994 Mar; 47(3):257-62. PubMed ID: 8163698
[TBL] [Abstract][Full Text] [Related]
12. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
Bansi DS; Fleming KA; Chapman RW
Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.
Roozendaal C; Horst G; Pogány K; van Milligen de Wit AW; Kleibeuker JH; Haagsma EB; Limburg PC; Kallenberg CG
Adv Exp Med Biol; 1998; 443():313-9. PubMed ID: 9781375
[TBL] [Abstract][Full Text] [Related]
15. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
[TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to cathepsin G in Crohn's disease.
Mayet WJ; Hermann E; Finsterwalder J; Rieder H; Poralla T; Meyer Zum Büschenfelde KH
Eur J Clin Invest; 1992 Jun; 22(6):427-33. PubMed ID: 1633838
[TBL] [Abstract][Full Text] [Related]
18. Methods of detection of anti-cathepsin G autoantibodies in human.
Lesavre P; Nusbaum P; Halbwachs-Mecarelli L
Adv Exp Med Biol; 1993; 336():257-61. PubMed ID: 8296615
[TBL] [Abstract][Full Text] [Related]
19. Detection and clinical associations of autoantibodies to myeloid granular proteins.
Tervaert JW
Adv Exp Med Biol; 1993; 336():299-302. PubMed ID: 8296621
[No Abstract] [Full Text] [Related]
20. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes.
Calafat J; Goldschmeding R; Ringeling PL; Janssen H; van der Schoot CE
Blood; 1990 Jan; 75(1):242-50. PubMed ID: 2153032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
